US 12,011,474 B2
Composition comprising a mixture of molecules extracted from Chrysanthellum indicum, Cynara scolymus and Lycium barbarum and use to act on carbohydrate and/or fat metabolism
Sebastien Peltier, Fouras (FR); Vivien Chavanelle, Clermont-Ferrand (FR); and Pascal Sirvent, Ceyrat (FR)
Assigned to VALBIOTIS, Perigny (FR); and UNIVERSITE CLERMONT AUVERGNE, Clermont-Ferrand (FR)
Filed by VALBIOTIS, Perigny (FR); and Universite Clermont Auvergne, Clermont-Ferrand (FR)
Filed on Aug. 11, 2020, as Appl. No. 16/990,290.
Application 16/990,290 is a continuation of application No. 15/769,876, granted, now 10,813,965, previously published as PCT/EP2016/075257, filed on Oct. 20, 2016.
Claims priority of application No. 1559965 (FR), filed on Oct. 20, 2015.
Prior Publication US 2020/0368303 A1, Nov. 26, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/287 (2006.01); A23L 33/105 (2016.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/197 (2006.01); A61K 31/4188 (2006.01); A61K 31/4525 (2006.01); A61K 31/455 (2006.01); A61K 31/51 (2006.01); A61K 31/519 (2006.01); A61K 31/525 (2006.01); A61K 31/593 (2006.01); A61K 31/675 (2006.01); A61K 31/714 (2006.01); A61K 33/24 (2019.01); A61K 33/30 (2006.01); A61K 35/747 (2015.01); A61K 36/28 (2006.01); A61K 36/45 (2006.01); A61K 36/63 (2006.01); A61K 36/67 (2006.01); A61K 36/815 (2006.01); A61K 45/06 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61K 35/00 (2006.01)
CPC A61K 36/287 (2013.01) [A23L 33/105 (2016.08); A61K 9/0095 (2013.01); A61K 9/2009 (2013.01); A61K 9/2054 (2013.01); A61K 9/4825 (2013.01); A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/197 (2013.01); A61K 31/4188 (2013.01); A61K 31/4525 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/593 (2013.01); A61K 31/675 (2013.01); A61K 31/714 (2013.01); A61K 33/24 (2013.01); A61K 33/30 (2013.01); A61K 35/747 (2013.01); A61K 36/28 (2013.01); A61K 36/45 (2013.01); A61K 36/63 (2013.01); A61K 36/67 (2013.01); A61K 36/815 (2013.01); A61K 45/06 (2013.01); A61P 3/06 (2018.01); A61P 3/10 (2018.01); A23V 2002/00 (2013.01); A61K 9/48 (2013.01); A61K 2035/115 (2013.01); A61K 2236/15 (2013.01); A61K 2236/333 (2013.01); A61K 2236/51 (2013.01)] 8 Claims
 
1. A tablet, capsule, powder, gel, emulsion or liquid for lowering levels of low-density lipoprotein cholesterol and triglycerides in the blood of a human, consisting essentially of therapeutically effective amount of a mixture of a Chrysanthellum indicum extract, Cynara scolymus extract, a Lycium barbarum extract, and an extract selected from the group consisting of piperine, Piper extract, Olea europeae extract, Vaccinium myrtillus extract and any combination thereof, wherein the Chrysanthellum indicum extract, the Cynara scolymus extract and the Lycium barbarum extracts are in a ratio from 0.001:0.001:0.001 to 10:10:10, respectively.